Large-scale testing (Phase 3)Study completedNCT05814627
What this trial is testing
Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis
Who this might be right for
Rheumatoid Arthritis
AbbVie 487